EXECUTIVE SUMMARY

Millions of people in America suffer from some kind of degenerative neurological condition. The American Parkinson’s Disease Association estimates that more than 1.5 million people in the United States have Parkinson’s disease. Epilepsy affects 3 million people according to the Epilepsy Foundation and The Alzheimer’s Association estimates that 4.5 million people have Alzheimer’s disease. An estimated 400,000 suffer from Multiple Sclerosis according to the National Multiple Sclerosis Society and 700,000 Americans experience a stroke each year. In fact, failure to receive appropriate treatment in time makes stroke the third leading cause of death according to the American Stroke Association.

With the huge burden of neurological disease set to grow and with the problems of an ageing population coming to the fore, up to date information needs to be readily available to the clinician. To address this need, Sovereign Medical is producing Neurology Insights USA to provide an in-depth analysis and overview of the current issues in neurological disease, focusing on the most relevant topics within migraine, stroke, epilepsy and neurodegenerative disorders, such as Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis.

The report will serve as a source of information for a targeted audience of medical doctors and professional caregivers involved in providing diagnosis, management and treatment regimens for a range of neurology related disorders.

The publication contains specially commissioned clinical and scientific editorial from the principal thought leaders and key opinion leaders from within the US neurology sector, providing new clinical developments and therapies.

EDITOR

Martyn Bracewell is the Editor of Neurology Insights USA and is a Senior Lecturer in Neurology and Neuroscience at the Wolfson Institute for Clinical and Cognitive Neuroscience at Bangor University, and a Consultant Neurologist at the Walton Centre for Neurology and Neurosurgery, Liverpool and the North Wales National Health Service Trusts. He read Medicine at Magdalen College, Oxford University and has a PhD in Neuroscience from the Massachusetts Institute of Technology. He did postgraduate training in Medicine at Oxford, and in Neurology at Oxford, the National Hospital for Neurology and Neurosurgery, Queen Square, London, and Birmingham, where he was the Lecturer in Neurology. His clinical and research interests in include Neuro-ophthalmology, Epilepsy, Behavioural Neurology and motor control.  

THOUGHT LEADER COLLABORATION

Neurology Insights USA draws on the expertise of key opinion leaders within the US neurology sector to ensure that it delivers world-class insights into the key developments and advancements within this vital clinical area.

Thought leaders and organisations who are being invited to contribute to the publication include:

ADVISORY PANEL

• Raymond Gibbons, President, American Stroke Association
• Harry Johns, President, Alzheimer’s Association
• Fred Shefftel, President, American Headache Society
• Joyse Nelson, President, National Multiple Sclerosis Society
• Stephen Sergay, President, American Academy of Neurology
• Vincent Gattullo, President, American Parkinson’s Disease Association
• Eric Hargis, President, Epilepsy Foundation
• P Wolf, President, International League Against Epilepsy

EDITORIAL CONTRIBUTORS

• David Simpson, MD, Professor of Neurology at Mount Sinai School of Medicine in New York
• Allison Brashear, M.D, Professor and Chair at Wakeforest University Department of Neurology
• Joseph Biederman, MD, Chief of the Clinical and Research Program in Pediatric Psychopharmacology at Massachusetts General Hospital
• Professor Olivera, Professor of Biology at the University of Utah,
• Stephen Silberstein, MD, Professor of Neurology, Jefferson Medical College of Thomas Jefferson University
• Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.
• Neal F. Kassell, M.D., Professor, Department of Neurosurgery at the University of Virginia
• Michael Thorpy, MD, Director, Sleep Wake Disorders Center; Montefiore Medical Center, Associate Professor of Neurology, Albert Einstein College of Medicine
• Professor Rachelle Doody, director of the Alzheimer's and Memory Disorders Center at the Baylor College of Medicine in Houston
• Professor Warren Olanow, Mount Sinai Hospital, Department of Neurology New York, NY, USA
• Dr. Jukka Peltola, Department of Neurology, Tampere University Hospital, Finland
• Dr. Patricia Crumrine, Director of the Pediatric Epilepsy Center and the EEG Laboratory, Children’s Hospital of Pittsburgh

SUPPORTING ORGANISATIONS

• Dystonia Medical Research Federation
• American Parkinson’s Disease Association
• Alzheimer’s Association
• American Neurological Society
• American Academy of Neurology
• American Stroke Association
• International Stroke Society
• National Multiple Sclerosis Society
• American Headache Society
• International League Against Epilepsy
• Epilepsy Foundation

CIRCULATION & READERSHIP

The key to the success of Neurology Insights USA is the quality of the circulation which covers the US primary and secondary care market.

The distribution includes:

Individual Clinics Medical Centres Public Hospitals Private Hospitals General Practices Private Practices Medical Associations

University Hospitals Research Hospitals General Purchasing Organisations Government Bodies Regulatory Bodies National Agencies for Medicines

Copies of Neurology Insights USA are distributed in both print and electronic format.

Neurologists Heads Of Neurology Consultant Neurologists Interventional Radiologists Paediatric Neurologists Neuro-Oncologists Neurosurgeons

Movement Disorder Specialists Epileptologists Gerontologists Heads Of Pharmacy Selected PCPs Neuropsychologists Psychiatrists

PACKAGE

We are able to provide you with

• The opportunity to nominate one author to write an independent unbiased white paper for the proposed feature running to approximately 2000 words
• A Search Engine Optimised Company Profile on the official Neurology Insights USA website
• A fully guaranteed precisely targeted circulation
• The reader response service in operation for 12 months after publication
• A complimentary copy of Neurology Insights USA upon publication
• A strategically placed advertisement in Neurology Insights USA or additional editorial if preferred

BENEFITS

• Target senior level physicians and clinicians throughout the European Neurology market engaged in the diagnosis, treatment and management of neurology related disorders.
• Generate enquiries and sales leads for your salespeople to follow up on.
• Demonstrate your commitment in this therapeutic area by sharing a platform with respected thought leaders and key opinion leaders.
• Increase your "share of voice" in the competitive market for neurology products.